Skip to search formSkip to main contentSkip to account menu

Vepesid

National Institutes of Health

Related topics

Related topics

3 relations
EpipodophyllotoxinVP 16-213

Broader (1)

Etoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Small cell carcinoma of rectum: a case report.
We present a case of a 40-year-old woman with small-cell carcinoma (SCC) of the rectum. She had profuse bleeding in rectum for 5… 
2004
2004
Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma
Methoxymorpholinyl doxorubicin (PNU 152243) is a morpholinyl analog possessing a methoxymorpholinyl group at the 3′ position of… 
2003
2003
Destructive Effect of DNA Topoisomerase II Inhibitor Vepesid on Mouse Spermatogenesis
Inhibition of DNA topoisomerase II with vepesid induced structural and functional reorganization of chromatin in meiotically… 
Review
1998
Review
1998
Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group.
Management of disseminated non-small-cell lung cancer has changed over the past 10 years. Newer agents, such as vinorelbine… 
1997
1997
A pilot phase 2 study of surgical treatment after induction chemotherapy for resectable stage I to IIIA small cell lung cancer.
BACKGROUND To evaluate the feasibility and efficacy of surgical resection of the primary tumor and regional lymph nodes in… 
1996
1996
Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis
A main feature in the pathogenesis of bacterial endocarditis is the activation of the coagulation system via the extrinsic… 
1995
1995
Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors.
PURPOSE To assess the pharmacokinetics and bioequivalence of etoposide following intravenous (i.v.) administration of etoposide… 
1992
1992
Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection.
1990
1990
Phase II clinical evaluation of etoposide (VP-16-213, Vepesid) as a second-line treatment in ovarian cancer. Results of the South-East European Oncology Group (SEEOG) Study.
The objective of this trial was to define the antitumor activity and toxicity of etoposide for second-line treatment of patients… 
1986
1986
Concurrent chemotherapy and radiotherapy for limited small-cell carcinoma of the lung: a Southwest Oncology Group Study.
This pilot study in limited-stage small-cell carcinoma of the lung using concurrent cisplatin (Platinol) and etoposide (VePesid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)